Abraaj Made ‘Significant’ Returns From Turkey Sale

Abraaj Capital, the Middle East’s biggest private equity firm with about $7 billion in assets, said it made “very significant” returns from the sale of its 50 percent stake in Turkey’s largest hospital chain.

Khazanah Nasional Bhd (KNBZ)., Malaysia’s state investment company, bought a 75 percent stake in Turkey’s Acibadem Saglik Yatirimlari A.S. and affiliated companies from Dubai-based Abraaj and Turkey’s Aydinlar family. The sale valued Acibadem Holding at about $1.68 billion for its entire Class A and Class B share capital, the companies said in December. The transaction was completed last week.

“We’ve made very significant returns,” Mustafa Abdel Wadood, chief executive officer of Abraaj Capital Ltd., said in an interview at the World Economic Forum in Davos, Switzerland. Abraaj’s 2007 investment in the company “was probably at the highest point in the cycle and the world then went into a deep financial crisis, but the business has grown.”

Since Abraaj’s investment, Acibadem expanded its hospital network from six to 14, and raised its bed capacity to 1,850 from 750, Abraaj said in a statement Jan. 24.

Earnings before interest, taxation, depreciation and amortization grew “by three to four times,” Abdel Wadood said.

Founded in 2002, Abraaj has raised more than $7 billion and has distributed about $3 billion to investors. Abraaj’s funds have holdings in more than 35 companies, including Air Arabia PJSC, the Middle East’s biggest low-cost airline.

To contact the reporter on this story: Alaa Shahine in Davos, Switzerland at asalha@bloomberg.net

To contact the editors responsible for this story: John Fraher at jfraher@bloomberg.net; Claudia Maedler at cmaedler@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.